Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Other Non-Current Assets (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Other Non-Current Assets data on record, last reported at $3.5 million in Q3 2025.

  • For Q3 2025, Other Non-Current Assets fell 0.59% year-over-year to $3.5 million; the TTM value through Sep 2025 reached $3.5 million, down 0.59%, while the annual FY2024 figure was $3.5 million, 0.45% changed from the prior year.
  • Other Non-Current Assets reached $3.5 million in Q3 2025 per SNTI's latest filing, up from $52000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $6.4 million in Q3 2023 and bottomed at $52000.0 in Q2 2025.
  • Average Other Non-Current Assets over 5 years is $2.6 million, with a median of $3.3 million recorded in 2022.
  • Peak YoY movement for Other Non-Current Assets: soared 1144.52% in 2023, then crashed 98.11% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $176000.0 in 2021, then skyrocketed by 60.8% to $283000.0 in 2022, then skyrocketed by 1144.52% to $3.5 million in 2023, then increased by 0.45% to $3.5 million in 2024, then grew by 0.06% to $3.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $3.5 million in Q3 2025, $52000.0 in Q2 2025, and $76000.0 in Q1 2025.